Immix Biopharma IMMX Declines 158 Amid Market Weakness 20260515 Amber Enterprises Shares Slide 18 on Q4 Results JV Losses and Margin Pressure Raise Concerns Lifevantage LFVN Q1 2026 Disappoints EPS 012 Below 016 Views The Rise of HALO Investing A New ETF Bets on Assets AI Cant Replace Northwest Bancshares Q1 2026 Earnings EPS Surges Past Consensus as Expense Discipline Supports Results BBVA Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline SHIP Q4 2025 Earnings EPS Surprises to the Upside Amid Robust Dry Bulk Market FRHC Q1 2026 Earnings Robust EPS of 125 Drives Stock Higher LNT Q1 2026 Earnings Earnings Beat Expectations with 712 Surprise Ready Capital Corporation Q1 2026 Earnings Deep Earnings Miss Highlights Operational Headwinds